Related Experiment Videos
Serum pancreatic lipase as a screening test for cystic fibrosis
Insights
Infants with cystic fibrosis show elevated pancreatic lipase levels in early life, mirroring higher trypsin levels. A new dried blood spot test for pancreatic lipase can screen neonates for cystic fibrosis.
Area of Science:
- Biochemistry
- Pediatrics
- Medical Diagnostics
Background:
- Pancreatic lipase is crucial for triglyceride digestion.
- Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, including the pancreas.
- Early diagnosis of CF is vital for timely intervention and improved outcomes.
Purpose of the Study:
- To investigate serum pancreatic lipase levels in neonates with cystic fibrosis.
- To compare these levels with those in healthy control infants.
- To evaluate a novel dried blood spot assay for pancreatic lipase as a neonatal screening tool for CF.
Main Methods:
- Measurement of serum pancreatic lipase levels in neonates with confirmed cystic fibrosis and in control infants.
- Utilized a turbidimetric assay on dried blood spots for pancreatic lipase quantification.
- Compared pancreatic lipase values with concurrently measured serum trypsin levels.
Main Results:
- Neonates with cystic fibrosis exhibited elevated serum pancreatic lipase levels during the initial weeks of life.
- These elevated pancreatic lipase levels were observed in parallel with elevated serum trypsin levels.
- The turbidimetric dried blood spot assay demonstrated simplicity and specificity.
Conclusions:
- Serum pancreatic lipase is elevated in neonates with cystic fibrosis.
- Pancreatic lipase measurement, particularly via a dried blood spot assay, shows potential as a screening method for neonatal cystic fibrosis.
- This assay offers a simple and specific approach for early CF detection in newborns.
Abstract:
Pancreatic lipase catalyses the hydrolysis of emulsified triglycerides to form a transparent solution of monoglycerides and fatty acids. Levels of serum pancreatic lipase were measured in neonates known to have cystic fibrosis and compared with levels in control infants. During the first weeks of life infants with cystic fibrosis had raised serum pancreatic lipase values in parallel with raised serum trypsin values. A simple and specific turbidimetric dried blood spot assay for serum pancreatic lipase was used as a screening test fo cystic fibrosis in the neonate.